AngioDynamics (ANGO) PT Raised to $21 at Piper Jaffray Amid Strong Q2
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
AngioDynamics (ANGO) Tops Q2 EPS by 2c; Boosts Outlook
January 8, 2015 4:07 PM ESTAngioDynamics (NASDAQ: ANGO) reported Q2 EPS of $0.17, $0.02 better than the analyst estimate of $0.15. Revenue for the quarter came in at $92.1 million versus the consensus estimate of $90.9 million.
AngioDynamics sees FY2015 EPS of $0.66-$0.72, versus the consensus of $0.69. AngioDynamics sees FY2015 revenue of $362-368 million, versus the consensus of $366.2 million.
"The strong sales momentum we established last fiscal year continued in the second quarter of FY15 as... More
